Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

Trinasolar has recently reached a significant milestone, delivering more than 1 GW of its Vertex N 720W series modules to the Jinsha River upstream clean energy plant. This project has now entered a ...

On Thursday Oct. 24, 2024, Ark Invest, led by Cathie Wood, sold 85,456 Tesla shares valued at $22.22 million amid the stock's ...

It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most major ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

On Wednesday, Vertex Pharmaceuticals Incorporated (VRTX) stock saw a decline, ending the day at $470.05 which represents a decrease of $-4.86 or -1.02% from the prior close of $474.91. The stock ...

Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in ...

ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Healthcare ETFs are an ideal investment choice for investors as they provide favorable returns, diversification, and robust ...

The industrial sector is seeing strong growth potential due to rising demand for machinery and services, boosted by advanced ...

Pediatric Orphan Drug Market is Segmented by Type (Oncology, Pulmonary, Neurology, Hematology, Endocrinology, Cardio-vascular ...